Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

6 OTC Painkillers That Are Exactly the Same Formula

When you shop for over-the-counter (OTC) painkillers, it’s easy to get overwhelmed by the number of brands and labels. Many people assume that different names mean different formulas. The truth is, several leading OTC painkillers are exactly the same formula, just packaged with different branding and prices. Understanding which painkillers…

Grocery Coupon Guide

‘I never noticed a difference’: Indiana woman buys can of Monster. Then she buys the same can—but it has a green tab

A TikTok content creator is warning her audience to be “careful” after consuming a few Monster energy drinks she posits are counterfeit. In a video with over 27,000 views, @thriftybuzinezz explained how she noticed a difference between cans with green and metallic-colored tabs.

The Mary Sue

Pfizer Birth Control Scandal: 1,000 Women Sue Over Brain Tumour Risk After Using Popular Contraceptive

Pfizer faces lawsuits from 1,000 women alleging Depo-Provera birth control caused brain tumours, amid new research showing higher meningioma risk.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Egg recall upgraded to FDA’s highest alert level indicating ‘reasonable probability’ of serious illness

The cases of eggs were recalled in September

The Independent UK

Kezar Launches Strategic Review As FDA Roadblock Derails Liver Drug Plans

Kezar Life Sciences, Inc. (NASDAQ:KZR) announced regulatory updates and began exploring strategic alternatives.

Benzinga

Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Friday.

Benzinga

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Friday.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Could simple blood tests identify cancer earlier?

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

LiveScience

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

The Food and Drug Administration announced on Thursday the first round of experimental drugs to be included in a priority voucher program. This FDA initiative is designed to expedite drug review processes for products that align with critical U.S. national health priorities, reducing review times from 10 to 12 months…

Benzinga

EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026

On Thursday, President Donald Trump announced the third agreement with a pharmaceutical manufacturer to bring American drug prices in line with the lowest paid by other developed nations, known as the most-favored-nation, or MFN price.

Benzinga

Protein powders and shakes contain high amounts of lead, new report says – a pharmacologist explains the data

Powder and ready-to-drink protein sales have exploded, reaching over US$32 billion globally from 2024 to 2025. Increasingly, consumers are using these protein sources daily.

The Conversation

What To Do If There’s a Shortage of Your Medications Due To Tariffs

Should you end up facing a shortage in your medications due to tariffs, or for other market-related availability issues, what should you do?

GOBankingRates

FDA unveils drugs to receive expedited review in support of 'national priorities'

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at the agency

The Independent UK

“Lean Lipo” Is the Newest Addition to the Body Contouring Toolkit

Meet "lean lipo"—the newest addition to the body contouring toolkit.

Marie Claire

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

The protein craze is heavy metal, literally: bombshell investigation finds unsafe lead amounts in two-thirds of top powders for sale

Paris Martineau said Consumer Reports found “concerning levels” of heavy metals in a 2010 investigation, but the risks have been growing ever since.

Barchart

This ‘Strong Buy’ Stock Has More Than Tripled Today. Should You Buy It Here?

Praxis shares soar as the biotech firm reports promising late-stage results for ulixacaltamide. Here’s why it may not be too late to invest in PRAX shares.

Benzinga

Novartis Strengthens Kidney Disease Pipeline With Promising Data

Novartis A/S (NYSE:NVS) on Thursday shared final results from the APPLAUSE-IgAN Phase 3 study evaluating Fabhalta (iptacopan) in adults with IgA nephropathy (IgAN).

The Independent UK

16 cinnamon brands to avoid after high levels of lead found in spice blends

Four brands have been added to the FDA’s ongoing health alert within the last week

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

There have currently been no reported illnesses as a result of the contamination, the FDA reports

The Independent UK

Powering up? Unsafe levels of lead found in top protein powder mixes, study finds

Supplements like protein powders are not regulated by the U.S. Food and Drug Administration

Kids Ain't Cheap

10 Children’s Medications That Were Recently Recalled

Image source: shutterstock.com

Benzinga

FDA Delays Decision Date For Denali Therapeutics' Lead Drug Candidate

The U.S. Food and Drug Administration extended on Monday Denali Therapeutics Inc.’s (NASDAQ:DNLI) review timeline of the Biologics License Application (BLA), seeking accelerated approval of tividenofusp alfa for the treatment of mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome.

Benzinga

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock

On Tuesday, the U.S. Food and Drug Administration (FDA) accepted Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) resubmission of the Biologics License Application (BLA) for Kresladi (marnetegragene autotemcel; marne-cel), a lentiviral vector (LV)-based investigational gene therapy for severe Leukocyte Adhesion Deficiency-I (LAD-I).

Benzinga

Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance

Telix Pharmaceuticals (NASDAQ:TLX) updated on Tuesday its commercial and operational performance for the third quarter of fiscal 2025.

The Independent UK

Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease

Millions of Americans are living with Alzheimer’s and hundreds of thousands are diagnosed each year

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.